The Short Version
The evidence does not support this statement. Official New Zealand sources indicate Community Services Card holders generally pay no co-payment for fully subsidised prescriptions from publicly funded or approved providers, not “about NZ$5.” In addition, the materials provided directly support funded sumatriptan but do not directly verify funded rizatriptan.